[{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-2978ec7e9ac23a465ccaacbb","output_id":"6aef68b40a2dab6ec0b3d981ad06729cd89fe931368f99cf5625b283db448000","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[],\"notes\":[],\"root\":null,\"status\":\"none\"}","error":"Nonempty requirements cannot be discarded","model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-2978ec7e9ac23a465ccaacbb","output_id":"6aef68b40a2dab6ec0b3d981ad06729cd89fe931368f99cf5625b283db448000","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence\"}],\"text\":\"Foundational knowledge in biology and pharmacology related to substance dependence.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"best practices for prescribing potentially addictive agents\"}],\"text\":\"Understanding of prescribing practices for addictive substances.\"}],\"search_phrases\":[\"substance dependence pharmacology\",\"prescribing addictive agents\",\"opioid pain management\",\"withdrawal management\",\"prescription drug monitoring\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Management of therapeutic tapering, withdrawal, and overdose.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"interpretation of urine drug tests, and use of prescription drug monitoring programs\"}],\"text\":\"Interpretation of drug tests and use of monitoring programs.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents\"}],\"text\":\"PHMSCI 640 covers the biological and pharmacological foundations of substance dependence and best practices for prescribing addictive agents.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"}],\"text\":\"Specific substance classes: opioids, cannabinoids, psychedelics, and amphetamines.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Clinical management: tapering, withdrawal, and overdose treatment.\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-2978ec7e9ac23a465ccaacbb","output_id":"6aef68b40a2dab6ec0b3d981ad06729cd89fe931368f99cf5625b283db448000","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"8b4e352055e5f370ff2e0d28fe45316305b36e794540c280444247b9791821bf","record_version_id":"e9e7278301323856c04603eb7cb36c800da32c0d0214a1fc5992fd00489bb4f5","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"48702b8982f4a716b11930e6a3129e5a2db2522dd209c5fb9365df8ea096d121","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[\"r1\",\"r2\"],\"condition\":null,\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"root\",\"kind\":\"any\"},{\"children\":[],\"condition\":\"Declared in Doctor of Pharmacy program with second year standing\",\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing\",\"id\":\"r1\",\"kind\":\"condition\"},{\"children\":[\"r2a\",\"r2b\"],\"condition\":null,\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"r2\",\"kind\":\"any\"},{\"children\":[],\"condition\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"id\":\"r2a\",\"kind\":\"condition\"},{\"children\":[],\"condition\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"r2b\",\"kind\":\"condition\"}],\"notes\":[\"The 'or' between the Doctor of Pharmacy path and the MS/Certificate paths is treated as an eligibility alternative.\"],\"root\":\"root\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"8b4e352055e5f370ff2e0d28fe45316305b36e794540c280444247b9791821bf","record_version_id":"e9e7278301323856c04603eb7cb36c800da32c0d0214a1fc5992fd00489bb4f5","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"48702b8982f4a716b11930e6a3129e5a2db2522dd209c5fb9365df8ea096d121","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[],\"assumed_background\":[],\"search_phrases\":[\"opioid prescribing best practices\",\"substance dependence pharmacology\",\"cannabinoids and psychedelics in medicine\",\"urine drug test interpretation\",\"prescription drug monitoring programs\",\"therapeutic tapering opioids\",\"overdose treatment substances of abuse\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":2,\"quote\":\"Apply best practices for prescribing opioids for acute and chronic pain, including initiation, titration, tapering, and opioid-sparing strategies\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Prescribing opioids for acute and chronic pain with initiation, titration, tapering, and opioid-sparing strategies\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Develop evidence-based treatment strategies for opioid use disorder and withdrawal management\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Developing evidence-based treatment strategies for opioid use disorder and withdrawal management\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":4,\"quote\":\"Interpret urine drug tests and Prescription Drug Monitoring Program data to inform clinical decision-making\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Interpreting urine drug tests and Prescription Drug Monitoring Program data for clinical decisions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":5,\"quote\":\"Identify and manage toxicity and overdose from known and unknown substances of abuse\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identifying and managing toxicity and overdose from known and unknown substances of abuse\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Examines the biological and pharmacological basis of substance dependence and prescribes potentially addictive agents, covering opioids, cannabinoids, psychedelics, amphetamines, and related substances.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Includes therapeutic tapering, withdrawal management, overdose treatment, interpretation of urine drug tests, and use of prescription drug monitoring programs.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Therapeutic tapering, withdrawal management, overdose treatment, urine drug test interpretation, and prescription drug monitoring programs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Differentiate between substance use, misuse, abuse, and dependence, and analyze their public health implications\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Differentiating substance use, misuse, abuse, and dependence with public health implications\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":6,\"quote\":\"Evaluate patterns of misuse in specific populations (e.g., athletes, students) and apply preventive strategies\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Evaluating misuse patterns in specific populations such as athletes and students and applying preventive strategies\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"8b4e352055e5f370ff2e0d28fe45316305b36e794540c280444247b9791821bf","record_version_id":"e9e7278301323856c04603eb7cb36c800da32c0d0214a1fc5992fd00489bb4f5","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"48702b8982f4a716b11930e6a3129e5a2db2522dd209c5fb9365df8ea096d121","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"8b4e352055e5f370ff2e0d28fe45316305b36e794540c280444247b9791821bf","record_version_id":"e9e7278301323856c04603eb7cb36c800da32c0d0214a1fc5992fd00489bb4f5","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"48702b8982f4a716b11930e6a3129e5a2db2522dd209c5fb9365df8ea096d121","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"fb7722aef2164492d0c4f24ccf7fa874f6aab207b420e408d36bdb4cb3a0e66e\",\"course_id\":\"PHMSCI 640\",\"current_instructors\":[{\"instructor_uid\":\"instructor_abfbb89baca506c12555a4c3\",\"message\":\"No course-specific reviews available\",\"name\":\"Shyanne Hefley\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]}],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":true,\"profile_hash\":\"3f5110430805ccdd533c0c072df62d68a8a5f5441c4530bbdb15d419a199a09c\",\"quick_take\":[{\"citations\":[{\"course_id\":\"PHMSCI 640\",\"run_id\":\"20261014T203208-0851c9a1\",\"source_record\":{\"entity_id\":\"0009e5ca-836c-3770-bf9e-7ad53caee832\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1104\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 640\",\"run_id\":\"20261014T203208-0851c9a1\",\"source_record\":{\"entity_id\":\"0009e5ca-836c-3770-bf9e-7ad53caee832\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1114\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 640\",\"run_id\":\"20261014T203208-0851c9a1\",\"source_record\":{\"entity_id\":\"0009e5ca-836c-3770-bf9e-7ad53caee832\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1124\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Spring 2010: 3.84 GPA, 96.3% A/AB (n=54 letter grades); Spring 2011: 3.66 GPA, 82.1% A/AB (n=28 letter grades); Spring 2012: 3.87 GPA, 100.0% A/AB (n=47 letter grades).\"}],\"student_experience\":[],\"task_hash\":\"9dea82ef7f2113a5605c1c6030c4f9b19967eb742cc93a78268fb92357d29f5c\",\"teaching_history\":[],\"term_id\":\"1274\",\"term_name\":\"2027 Sprng\",\"version\":3}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"02f57195bb8cd8f8fbb4b8184eed0acc8b1c0b2eb8b10b11ddc9e6ebc776f72e","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[{\"children\":[\"n1\",\"n2\"],\"condition\":null,\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"n0\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":0,\"minimum_grade\":null,\"subjects\":[\"PHARMACY\"],\"timing\":\"prior\"},\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing\",\"id\":\"n1\",\"kind\":\"course\"},{\"children\":[],\"condition\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"n2\",\"kind\":\"condition\"}],\"notes\":[\"PHARMACY 0 is a placeholder for 'Doctor of Pharmacy program'; canonical course ID not found in linked_courses.\"],\"root\":\"n0\",\"status\":\"needs_review\"}","error":"Course requirement is absent from the source links","model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"02f57195bb8cd8f8fbb4b8184eed0acc8b1c0b2eb8b10b11ddc9e6ebc776f72e","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence\"}],\"text\":\"Foundational knowledge in biology and pharmacology related to substance dependence.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"best practices for prescribing potentially addictive agents\"}],\"text\":\"Understanding of prescribing practices for addictive substances.\"}],\"search_phrases\":[\"substance dependence pharmacology\",\"prescribing addictive agents\",\"opioid pain management\",\"withdrawal management\",\"prescription drug monitoring\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Management of therapeutic tapering, withdrawal, and overdose.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"interpretation of urine drug tests, and use of prescription drug monitoring programs\"}],\"text\":\"Interpretation of drug tests and use of monitoring programs.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents\"}],\"text\":\"PHMSCI 640 covers the biological and pharmacological foundations of substance dependence and best practices for prescribing addictive agents.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"}],\"text\":\"Specific substance classes: opioids, cannabinoids, psychedelics, and amphetamines.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Clinical management: tapering, withdrawal, and overdose treatment.\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"02f57195bb8cd8f8fbb4b8184eed0acc8b1c0b2eb8b10b11ddc9e6ebc776f72e","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"9d7d635bd3a674a6b2b7581616a4939f5fcda43f68e838e0f2e5c36bfe8726bf","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[\"dop_standing\",\"ms_program\",\"capstone_cert\"],\"condition\":null,\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"root\",\"kind\":\"all\"},{\"children\":[],\"condition\":\"Declared in Doctor of Pharmacy program with second year standing\",\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing\",\"id\":\"dop_standing\",\"kind\":\"condition\"},{\"children\":[],\"condition\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"id\":\"ms_program\",\"kind\":\"condition\"},{\"children\":[],\"condition\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"capstone_cert\",\"kind\":\"condition\"}],\"notes\":[\"The requirements are based on program standing or certificates, not specific course prerequisites. No linked courses were provided to reference.\"],\"root\":\"root\",\"status\":\"needs_review\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"9d7d635bd3a674a6b2b7581616a4939f5fcda43f68e838e0f2e5c36bfe8726bf","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence\"}],\"text\":\"Foundational knowledge in biology and pharmacology related to substance dependence.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"best practices for prescribing potentially addictive agents\"}],\"text\":\"Understanding of prescribing practices for addictive substances.\"}],\"search_phrases\":[\"substance dependence pharmacology\",\"prescribing addictive agents\",\"opioid pain management\",\"withdrawal management\",\"prescription drug monitoring\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Management of therapeutic tapering, withdrawal, and overdose.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"interpretation of urine drug tests, and use of prescription drug monitoring programs\"}],\"text\":\"Interpretation of drug tests and use of monitoring programs.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents\"}],\"text\":\"PHMSCI 640 covers the biological and pharmacological foundations of substance dependence and best practices for prescribing addictive agents.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"}],\"text\":\"Specific substance classes: opioids, cannabinoids, psychedelics, and amphetamines.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Clinical management: tapering, withdrawal, and overdose treatment.\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"9d7d635bd3a674a6b2b7581616a4939f5fcda43f68e838e0f2e5c36bfe8726bf","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"8b4e352055e5f370ff2e0d28fe45316305b36e794540c280444247b9791821bf","record_version_id":"e9e7278301323856c04603eb7cb36c800da32c0d0214a1fc5992fd00489bb4f5","job_id":"enrich-6556a505c10f448d98d02466","output_id":"87f4aba7f96622eda4d085019c7760c8688e6379606a566d7b4d8f9bfc24046b","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[\"r1\",\"r2\"],\"condition\":null,\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"root\",\"kind\":\"any\"},{\"children\":[],\"condition\":\"Declared in Doctor of Pharmacy program with second year standing\",\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing\",\"id\":\"r1\",\"kind\":\"condition\"},{\"children\":[\"r2a\",\"r2b\"],\"condition\":null,\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"r2\",\"kind\":\"any\"},{\"children\":[],\"condition\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"id\":\"r2a\",\"kind\":\"condition\"},{\"children\":[],\"condition\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"r2b\",\"kind\":\"condition\"}],\"notes\":[\"The 'or' between the Doctor of Pharmacy path and the MS/Certificate paths is treated as an eligibility alternative.\"],\"root\":\"root\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"8b4e352055e5f370ff2e0d28fe45316305b36e794540c280444247b9791821bf","record_version_id":"e9e7278301323856c04603eb7cb36c800da32c0d0214a1fc5992fd00489bb4f5","job_id":"enrich-6556a505c10f448d98d02466","output_id":"87f4aba7f96622eda4d085019c7760c8688e6379606a566d7b4d8f9bfc24046b","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[],\"assumed_background\":[],\"search_phrases\":[\"opioid prescribing best practices\",\"substance dependence pharmacology\",\"cannabinoids and psychedelics in medicine\",\"urine drug test interpretation\",\"prescription drug monitoring programs\",\"therapeutic tapering opioids\",\"overdose treatment substances of abuse\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":2,\"quote\":\"Apply best practices for prescribing opioids for acute and chronic pain, including initiation, titration, tapering, and opioid-sparing strategies\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Prescribing opioids for acute and chronic pain with initiation, titration, tapering, and opioid-sparing strategies\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Develop evidence-based treatment strategies for opioid use disorder and withdrawal management\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Developing evidence-based treatment strategies for opioid use disorder and withdrawal management\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":4,\"quote\":\"Interpret urine drug tests and Prescription Drug Monitoring Program data to inform clinical decision-making\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Interpreting urine drug tests and Prescription Drug Monitoring Program data for clinical decisions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":5,\"quote\":\"Identify and manage toxicity and overdose from known and unknown substances of abuse\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identifying and managing toxicity and overdose from known and unknown substances of abuse\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Examines the biological and pharmacological basis of substance dependence and prescribes potentially addictive agents, covering opioids, cannabinoids, psychedelics, amphetamines, and related substances.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Includes therapeutic tapering, withdrawal management, overdose treatment, interpretation of urine drug tests, and use of prescription drug monitoring programs.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Therapeutic tapering, withdrawal management, overdose treatment, urine drug test interpretation, and prescription drug monitoring programs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Differentiate between substance use, misuse, abuse, and dependence, and analyze their public health implications\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Differentiating substance use, misuse, abuse, and dependence with public health implications\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"official_learning_outcomes\",\"outcome_index\":6,\"quote\":\"Evaluate patterns of misuse in specific populations (e.g., athletes, students) and apply preventive strategies\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Evaluating misuse patterns in specific populations such as athletes and students and applying preventive strategies\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"8b4e352055e5f370ff2e0d28fe45316305b36e794540c280444247b9791821bf","record_version_id":"e9e7278301323856c04603eb7cb36c800da32c0d0214a1fc5992fd00489bb4f5","job_id":"enrich-6556a505c10f448d98d02466","output_id":"87f4aba7f96622eda4d085019c7760c8688e6379606a566d7b4d8f9bfc24046b","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-789789da373eecc1ff75f626","output_id":"895256a3f1b83fa5764d80855a1f37736589ec444ea91706dcd5d57227ad8efb","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[{\"children\":[\"n1\",\"n2\"],\"condition\":null,\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"n0\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":0,\"minimum_grade\":null,\"subjects\":[\"PHARMACY\"],\"timing\":\"prior\"},\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing\",\"id\":\"n1\",\"kind\":\"course\"},{\"children\":[],\"condition\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"n2\",\"kind\":\"condition\"}],\"notes\":[\"Source URL lacks specific program requirement details.\"],\"root\":\"n0\",\"status\":\"parsed\"}","error":"Course requirement is absent from the source links","model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-789789da373eecc1ff75f626","output_id":"895256a3f1b83fa5764d80855a1f37736589ec444ea91706dcd5d57227ad8efb","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence\"}],\"text\":\"Foundational knowledge in biology and pharmacology related to substance dependence.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"best practices for prescribing potentially addictive agents\"}],\"text\":\"Understanding of prescribing practices for addictive substances.\"}],\"search_phrases\":[\"substance dependence pharmacology\",\"prescribing addictive agents\",\"opioid pain management\",\"withdrawal management\",\"prescription drug monitoring\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Management of therapeutic tapering, withdrawal, and overdose.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"interpretation of urine drug tests, and use of prescription drug monitoring programs\"}],\"text\":\"Interpretation of drug tests and use of monitoring programs.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents\"}],\"text\":\"PHMSCI 640 covers the biological and pharmacological foundations of substance dependence and best practices for prescribing addictive agents.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"}],\"text\":\"Specific substance classes: opioids, cannabinoids, psychedelics, and amphetamines.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Clinical management: tapering, withdrawal, and overdose treatment.\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-789789da373eecc1ff75f626","output_id":"895256a3f1b83fa5764d80855a1f37736589ec444ea91706dcd5d57227ad8efb","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"c7476ed41a84ef8d026c7f977e3032c0ab037c8c784e0cc73237784fa37182a4","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[\"dop_standing\",\"ms_program\",\"capstone_cert\"],\"condition\":null,\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing or MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation or Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"root\",\"kind\":\"all\"},{\"children\":[],\"condition\":\"Declared in Doctor of Pharmacy program with second year standing\",\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program with second year standing\",\"id\":\"dop_standing\",\"kind\":\"condition\"},{\"children\":[],\"condition\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"id\":\"ms_program\",\"kind\":\"condition\"},{\"children\":[],\"condition\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"Capstone Certificate in Psychoactive Pharmaceutical Investigation\",\"id\":\"capstone_cert\",\"kind\":\"condition\"}],\"notes\":[\"The requirements are based on program standing or certificates, not specific course prerequisites. No linked courses were provided to reference.\"],\"root\":\"root\",\"status\":\"needs_review\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"c7476ed41a84ef8d026c7f977e3032c0ab037c8c784e0cc73237784fa37182a4","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence\"}],\"text\":\"Foundational knowledge in biology and pharmacology related to substance dependence.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"best practices for prescribing potentially addictive agents\"}],\"text\":\"Understanding of prescribing practices for addictive substances.\"}],\"search_phrases\":[\"substance dependence pharmacology\",\"prescribing addictive agents\",\"opioid pain management\",\"withdrawal management\",\"prescription drug monitoring\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Management of therapeutic tapering, withdrawal, and overdose.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"interpretation of urine drug tests, and use of prescription drug monitoring programs\"}],\"text\":\"Interpretation of drug tests and use of monitoring programs.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents\"}],\"text\":\"PHMSCI 640 covers the biological and pharmacological foundations of substance dependence and best practices for prescribing addictive agents.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"}],\"text\":\"Specific substance classes: opioids, cannabinoids, psychedelics, and amphetamines.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Clinical management: tapering, withdrawal, and overdose treatment.\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"c7476ed41a84ef8d026c7f977e3032c0ab037c8c784e0cc73237784fa37182a4","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"c7476ed41a84ef8d026c7f977e3032c0ab037c8c784e0cc73237784fa37182a4","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"2fab6cb30fcd8062c71954986b30a7b0e9f731cd279e657aa529604a53476b26\",\"course_id\":\"PHMSCI 640\",\"current_instructors\":[],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":false,\"profile_hash\":\"5cb4dabf887cdbcd8c00d5a1312e10828b95c63f30bc3ea76aea199565390d02\",\"quick_take\":[{\"citations\":[{\"course_id\":\"PHMSCI 640\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"0009e5ca-836c-3770-bf9e-7ad53caee832\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1104\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 640\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"0009e5ca-836c-3770-bf9e-7ad53caee832\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1114\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 640\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"0009e5ca-836c-3770-bf9e-7ad53caee832\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1124\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Spring 2010: 3.84 GPA, 96.3% A/AB (n=54 letter grades); Spring 2011: 3.66 GPA, 82.1% A/AB (n=28 letter grades); Spring 2012: 3.87 GPA, 100.0% A/AB (n=47 letter grades).\"}],\"student_experience\":[],\"task_hash\":\"74fb0997943e888960bbc9e47db8c4fd12e4292d55c20509d8d89db6a9910f68\",\"teaching_history\":[],\"term_id\":\"1272\",\"term_name\":\"2026 Fall\",\"version\":2}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-dab8f6acaa72f26086773521","output_id":"9e028a73e756ae2826bfa28431bfce64e7d50304d7b4c40812d379a46ae4997a","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[],\"notes\":[],\"root\":null,\"status\":\"none\"}","error":"Nonempty requirements cannot be discarded","model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-dab8f6acaa72f26086773521","output_id":"9e028a73e756ae2826bfa28431bfce64e7d50304d7b4c40812d379a46ae4997a","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence\"}],\"text\":\"Foundational knowledge in biology and pharmacology related to substance dependence.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"best practices for prescribing potentially addictive agents\"}],\"text\":\"Understanding of prescribing practices for addictive substances.\"}],\"search_phrases\":[\"substance dependence pharmacology\",\"prescribing addictive agents\",\"opioid pain management\",\"withdrawal management\",\"prescription drug monitoring\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Management of therapeutic tapering, withdrawal, and overdose.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"interpretation of urine drug tests, and use of prescription drug monitoring programs\"}],\"text\":\"Interpretation of drug tests and use of monitoring programs.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"title\",\"quote\":\"APPROPRIATE USE OF ABUSED DRUGS\"},{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Explores biological and pharmacological foundations of substance dependence and best practices for prescribing potentially addictive agents\"}],\"text\":\"PHMSCI 640 covers the biological and pharmacological foundations of substance dependence and best practices for prescribing addictive agents.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"Covers opioids for pain management, cannabinoids, psychedelics, amphetamines, and related substances\"}],\"text\":\"Specific substance classes: opioids, cannabinoids, psychedelics, and amphetamines.\"},{\"evidence\":[{\"course_id\":\"PHMSCI 640\",\"field\":\"description\",\"quote\":\"therapeutic tapering, withdrawal management, overdose treatment\"}],\"text\":\"Clinical management: tapering, withdrawal, and overdose treatment.\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_6f31cad7c7eda11ec2443b72","course_id":"PHMSCI 640","catalog_version_id":"4fce462a8014d57daf84cd9faadbd55f1ca2824e59702158a62508f902878eb4","record_version_id":"74b57dab009a9801b85f24d2918e7b6e190abc12d44cbcc96db1efac827bd430","job_id":"enrich-dab8f6acaa72f26086773521","output_id":"9e028a73e756ae2826bfa28431bfce64e7d50304d7b4c40812d379a46ae4997a","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false}]